These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2666051)

  • 61. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.
    Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B
    APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.
    Liang JT; Cheng YM; Chang KJ; Chien CT; Hsu HC
    Hepatogastroenterology; 1999; 46(26):830-7. PubMed ID: 10370622
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amplification of c-Ki-ras-2 oncogene sequences in human carcinoma of pancreas.
    Parsa I; Pour PM; Cleary CM
    Int J Pancreatol; 1988; 3(1):45-51. PubMed ID: 3280705
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oncogene alterations in in vitro transformed rat tracheal epithelial cells.
    Mass MJ; Schorschinsky NS; Lasley JA; Beeman DK; Austin SJ
    Mutat Res; 1990 Apr; 243(4):291-8. PubMed ID: 1691445
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9.
    Allen DC; Foster H; Orchin JC; Biggart JD
    J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
    Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Determination of the activated proto-oncogene (Ki-ras) in feces. A new laboratory analysis for early diagnosis of colorectal cancer].
    Koornstra JJ; Røkke O; Halvorsen JF; Haug K; Ogreid D
    Tidsskr Nor Laegeforen; 1995 Oct; 115(26):3266-70. PubMed ID: 7482456
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Point mutations of c-ras genes in human bladder cancer and kidney cancer.
    Nagata Y; Abe M; Kobayashi K; Saiki S; Kotake T; Yoshikawa K; Ueda R; Nakayama E; Shiku H
    Jpn J Cancer Res; 1990 Jan; 81(1):22-7. PubMed ID: 2108944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ki-ras point mutation in different types of colorectal carcinomas in early stages.
    Kojima M; Konishi F; Tsukamoto T; Yamashita K; Kanazawa K
    Dis Colon Rectum; 1997 Feb; 40(2):161-7. PubMed ID: 9075750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
    Kasper HU; Schneider-Stock R; Mellin W; Roessner A
    Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon.
    Jansson DS; Radosevich JA; Carney WP; Rosen ST; Schlom J; Staren ED; Hyser MJ; Gould VE
    Cancer; 1990 Mar; 65(6):1329-37. PubMed ID: 2407334
    [TBL] [Abstract][Full Text] [Related]  

  • 74. DNA distribution pattern of the so-called severe dysplasias and small carcinomas of the colon and rectum and its possible significance in the tumor progression.
    Hamada S; Itoh R; Fujita S
    Cancer; 1988 Apr; 61(8):1555-62. PubMed ID: 2450631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma.
    Michelassi F; Erroi F; Roncella M; Block GE
    Dis Colon Rectum; 1989 Aug; 32(8):665-8. PubMed ID: 2666052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Flow-cytometric demonstration of tumour-cell subpopulations with different DNA content in human colo-rectal carcinoma.
    Petersen SE; Bichel P; Lorentzen M
    Eur J Cancer (1965); 1979 Apr; 15(4):383-6. PubMed ID: 436903
    [No Abstract]   [Full Text] [Related]  

  • 78. Localization of H-ras mRNA in oral squamous cell carcinomas.
    Hoellering J; Shuler CF
    J Oral Pathol Med; 1989 Feb; 18(2):74-8. PubMed ID: 2664134
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevalence of ras gene mutations in human colorectal cancers.
    Bos JL; Fearon ER; Hamilton SR; Verlaan-de Vries M; van Boom JH; van der Eb AJ; Vogelstein B
    Nature; 1987 May 28-Jun 3; 327(6120):293-7. PubMed ID: 3587348
    [TBL] [Abstract][Full Text] [Related]  

  • 80. DNA content in carcinoma of the rectum and rectosigmoid.
    Enblad P; Glimelius B; Bengtsson A; Pontén J; Påhlman L
    Acta Pathol Microbiol Immunol Scand A; 1985 Sep; 93(5):277-84. PubMed ID: 4050436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.